Neuropace, Inc. NPCE Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s gain/loss on asset sales?
- Neuropace, Inc. (NPCE) reported gain/loss on asset sales of $0 in Q1 2026.
- How has Neuropace, Inc.'s gain/loss on asset sales changed year-over-year?
- Neuropace, Inc.'s gain/loss on asset sales increased by 100.0% year-over-year, from -$2K to $0.
- What does gain/loss on asset sales mean?
- Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.